Analystreport

Adaptive Biotechnologies Co. (NASDAQ: ADPT) had its price target raised by analysts at Scotiabank from $10.00 to $12.00. They now have a "sector outperform" rating on the stock.

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com